These various responses to treatment in different cancer types appear to have a sound basis in tumour biology, and it is not unforeseeable that such differences to treatment response and TP53 mutation status may also occur in different HNSCC subtypes. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.